The Use of Stimulant Augmentation of Second Generation Antipsychotics in the Management of Negative Symptoms of Schizophrenia: A Case Report
Azizi H, Zeng Y, Kallikkadan J, Kahn A, Olayinka O, Popoola O, Khan T, Rimawi D, Malik A, Williams S, Langdon S, Obegolu C, Nuthalapati D, Alzear R, Kalbouneh H, Mahbub A, Ojimba C, Oyelakin A, Kodjo K, Ferdous Saad A, Jegede O, Jolayemi A. The Use of Stimulant Augmentation of Second Generation Antipsychotics in the Management of Negative Symptoms of Schizophrenia: A Case Report. International Journal Of Innovative Research In Medical Science 2018, 3 DOI: 10.23958/ijirms/vol03-i08/08.Peer-Reviewed Original ResearchNegative symptomsMesocortical pathwayStimulant medicationSymptom subscalesTwo-point reductionClasses of medicationsSecond-generation antipsychoticsPositive symptom subscaleThree-week trialNegative symptom subscaleAntipsychotic therapyNegative syndrome scoreGeneration antipsychoticsCase reportSyndrome scoreDopamine activityMedicationsSymptomsSchizophreniaThree-week periodScoresPotential benefitsSubscales